| Dr John F Kozlovsky, MD,PA | |
|
2929 Mossrock, Suite 104, San Antonio, TX 78230-5141 | |
| (210) 377-0350 | |
| (210) 377-2982 |
| Full Name | Dr John F Kozlovsky |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 2929 Mossrock, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063401255 | NPI | - | NPPES |
| 110654401 | Medicaid | TX | |
| 180040180 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | J0050 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr. John F Kozlovsky Md Pa | 1254485543 | 2 |
News Archive
Forest Laboratories, Inc. and Nycomed today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for roflumilast. Roflumilast was reviewed as a potential treatment to reduce COPD exacerbations associated with chronic bronchitis in patients at risk for exacerbations.
Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
Infections caused by foodborne microorganisms are an increasing public health burden. In a PhD project at the National Food Institute, Technical University of Denmark, new methods of characterising and dectecting foodborne illness-causing Salmonella in pork meat processing and in bacteria in water, feed and food samples were studied.
State leaders have significant power to curb rising health care costs and they should lead the effort, advises a commission co-chaired by two former governors. Meanwhile, a Massachusetts state report concludes that more than a third of health-care spending in that state each year may be wasteful.
A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.
› Verified 5 days ago
| Entity Name | Dr. John F Kozlovsky Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093949000 PECOS PAC ID: 1254485543 Enrollment ID: O20090820000884 |
News Archive
Forest Laboratories, Inc. and Nycomed today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for roflumilast. Roflumilast was reviewed as a potential treatment to reduce COPD exacerbations associated with chronic bronchitis in patients at risk for exacerbations.
Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
Infections caused by foodborne microorganisms are an increasing public health burden. In a PhD project at the National Food Institute, Technical University of Denmark, new methods of characterising and dectecting foodborne illness-causing Salmonella in pork meat processing and in bacteria in water, feed and food samples were studied.
State leaders have significant power to curb rising health care costs and they should lead the effort, advises a commission co-chaired by two former governors. Meanwhile, a Massachusetts state report concludes that more than a third of health-care spending in that state each year may be wasteful.
A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John F Kozlovsky, MD,PA 2929 Mossrock, Suite 104, San Antonio, TX 78230-5141 Ph: (210) 377-0350 | Dr John F Kozlovsky, MD,PA 2929 Mossrock, Suite 104, San Antonio, TX 78230-5141 Ph: (210) 377-0350 |
News Archive
Forest Laboratories, Inc. and Nycomed today announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for roflumilast. Roflumilast was reviewed as a potential treatment to reduce COPD exacerbations associated with chronic bronchitis in patients at risk for exacerbations.
Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
Infections caused by foodborne microorganisms are an increasing public health burden. In a PhD project at the National Food Institute, Technical University of Denmark, new methods of characterising and dectecting foodborne illness-causing Salmonella in pork meat processing and in bacteria in water, feed and food samples were studied.
State leaders have significant power to curb rising health care costs and they should lead the effort, advises a commission co-chaired by two former governors. Meanwhile, a Massachusetts state report concludes that more than a third of health-care spending in that state each year may be wasteful.
A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.
› Verified 5 days ago
Dr. Robert Alan Rice, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Haven For Hope Way, San Antonio, TX 78207 Phone: 102-220-2368 Fax: 210-220-2499 | |
Dr. Ricardo Nathaniel Sepulveda, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8002 West Ave, San Antonio, TX 78213 Phone: 210-348-8788 Fax: 210-348-8768 | |
Aaron Pittard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11601 Toepperwein Rd, San Antonio, TX 78233 Phone: 210-946-2020 | |
Dr. Wendy Baca, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10935 Wurzbach, #202, San Antonio, TX 78230 Phone: 210-377-3937 Fax: 210-342-2375 | |
Fernando Trujillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 E Basse Rd, Ste 103, San Antonio, TX 78209 Phone: 210-538-2020 Fax: 210-599-6622 | |
Dr. Barbara L. Ku, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 N Main Ave, San Antonio, TX 78212 Phone: 210-222-2154 Fax: 210-227-6056 | |
Dr. Gregory Brunin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5430 Fredericksburg Rd Ste 100, San Antonio, TX 78229 Phone: 210-340-1212 |